Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Alric

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Gastroenterology|November 14, 1997
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infectionL Alric, M Fort, J Izopet, et al.
Journal of Virology|January 7, 2000
Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapyK Sandres, M Dubois, C Pasquier, et al.
The Journal of Infectious Diseases|March 19, 2019
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 InfectionC Loiseau, M Requena, M Nayrac, et al.
Journal of Hepatology|October 3, 2001
Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trialL Alric, M Duffaut, J Selves, et al.
Mucosal Immunology|February 18, 2016
CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individualsC Loiseau, M Requena, M Mavigner, et al.
La Revue De Medecine Interne|November 1, 2019
[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update]T Comont, J Belliere, V Sibaud, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2008
Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver diseaseC Bureau, S Metivier, J M Peron, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Enterovenous fistula. An unusual complication of Crohn disease]J L Payen, L Alric, F De Haldat, et al.
The Journal of Infectious Diseases|December 12, 1997
High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapyJ Izopet, L Rostaing, F Moussion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 21, 2015
Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney TransplantationN Kamar, O Marion, L Rostaing, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Gastroenterology|November 14, 1997
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infectionL Alric, M Fort, J Izopet, et al.
Journal of Virology|January 7, 2000
Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapyK Sandres, M Dubois, C Pasquier, et al.
The Journal of Infectious Diseases|March 19, 2019
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 InfectionC Loiseau, M Requena, M Nayrac, et al.
Journal of Hepatology|October 3, 2001
Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trialL Alric, M Duffaut, J Selves, et al.
Mucosal Immunology|February 18, 2016
CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individualsC Loiseau, M Requena, M Mavigner, et al.
La Revue De Medecine Interne|November 1, 2019
[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update]T Comont, J Belliere, V Sibaud, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2008
Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver diseaseC Bureau, S Metivier, J M Peron, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Enterovenous fistula. An unusual complication of Crohn disease]J L Payen, L Alric, F De Haldat, et al.
The Journal of Infectious Diseases|December 12, 1997
High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapyJ Izopet, L Rostaing, F Moussion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 21, 2015
Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney TransplantationN Kamar, O Marion, L Rostaing, et al.
Pageof 8